| Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men DW Cameron, LJ D'Costa, GM Maitha, M Cheang, P Piot, JN Simonsen, ... The Lancet 334 (8660), 403-407, 1989 | 1105 | 1989 |
| Cofactors in male-female sexual transmission of human immunodeficiency virus type 1 FA Plummer, JN Simonsen, DW Cameron, JO Ndinya-Achola, JK Kreiss, ... Journal of infectious diseases 163 (2), 233-239, 1991 | 1038 | 1991 |
| A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? JA Røttingen, DW Cameron, GP Garnett Sexually transmitted diseases 28 (10), 579-597, 2001 | 783 | 2001 |
| Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease DW Cameron, M Heath-Chiozzi, S Danner, C Cohen, S Kravcik, ... The Lancet 351 (9102), 543-549, 1998 | 725 | 1998 |
| Human immunodeficiency virus infection among men with sexually transmitted diseases JN Simonsen, DW Cameron, MN Gakinya, JO Ndinya-Achola, LJ D'Costa, ... New England Journal of Medicine 319 (5), 274-278, 1988 | 535 | 1988 |
| Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS SD Nightingale, DW Cameron, FM Gordin, PM Sullam, DL Cohn, ... New England Journal of Medicine 329 (12), 828-833, 1993 | 486 | 1993 |
| CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study CL Cooper, HL Davis, ML Morris, SM Efler, MAL Adhami, AM Krieg, ... Journal of clinical immunology 24, 693-701, 2004 | 429 | 2004 |
| Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes EN Ngugi, JN Simonsen, M Bosire, AR Ronald, FA Plummer, ... The Lancet 332 (8616), 887-890, 1988 | 317 | 1988 |
| Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine CL Cooper, HL Davis, ML Morris, SM Efler, AM Krieg, Y Li, C Laframboise, ... Vaccine 22 (23-24), 3136-3143, 2004 | 316 | 2004 |
| Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies VF Corrales-Medina, KN Suh, G Rose, JA Chirinos, S Doucette, ... PLoS medicine 8 (6), e1001048, 2011 | 310 | 2011 |
| Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects C la Porte, N Voduc, G Zhang, I Seguin, D Tardiff, N Singhal, ... Clinical pharmacokinetics 49, 449-454, 2010 | 281 | 2010 |
| CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults CL Cooper, HL Davis, JB Angel, ML Morris, SM Elfer, I Seguin, AM Krieg, ... Aids 19 (14), 1473-1479, 2005 | 259 | 2005 |
| Ritonavir and saquinavir combination therapy for the treatment of HIV infection W Cameron, AJ Japour, Y Xu, A Hsu, J Mellors, C Farthing, C Cohen, ... Aids 13 (2), 213-224, 1999 | 254 | 1999 |
| The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention J Pepin, FA Plummer, RC Brunham, P Piot, WD Cameron, AR Ronald Aids 3 (1), 3-9, 1989 | 254 | 1989 |
| Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya GB Moss, D Clemetson, L D'Costa, FA Plummer, JO Ndinya-Achola, ... Journal of Infectious Diseases 164 (3), 588-591, 1991 | 249 | 1991 |
| Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection J Sahai, K Gallicano, L Swick, S Tailor, G Garber, I Seguin, L Oliveras, ... Annals of internal medicine 127 (4), 289-293, 1997 | 234 | 1997 |
| Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis AF Turgeon, B Hutton, DA Fergusson, L McIntyre, AA Tinmouth, ... Annals of internal medicine 146 (3), 193-203, 2007 | 232 | 2007 |
| A review of low-dose ritonavir in protease inhibitor combination therapy CL Cooper, RPG Van Heeswijk, K Gallicano, DW Cameron Clinical infectious diseases 36 (12), 1585-1592, 2003 | 204 | 2003 |
| Safe use of the CXCR4 inhibitor ALX40-4C in humans BJ Doranz, LG Filion, F Diaz-Mitoma, DS Sitar, J Sahai, F Baribaud, ... AIDS research and human retroviruses 17 (6), 475-486, 2001 | 176 | 2001 |
| A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy DW Cameron, BA da Silva, JR Arribas, RA Myers, NC Bellos, N Gilmore, ... The Journal of infectious diseases 198 (2), 234-240, 2008 | 156 | 2008 |
Plummer FAUniversity of ManitobaVerified email at phac-aspc.gc.ca
